DNLI's BLA for Hunter Syndrome Drug Gets FDA's Priority Review - MSN
4 days ago • Google News
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutics to treat neurodegenerative and lysosomal storage diseases.
4 days ago • Google News
3 weeks ago • Google News